Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pongpan Tanajak"'
Publikováno v:
Molecules, Vol 28, Iss 11, p 4294 (2023)
Doxorubicin (Dox) is one of the most frequently used chemotherapeutic drugs in a variety of cancers, but Dox-induced cardiotoxicity diminishes its therapeutic efficacy. The underlying mechanisms of Dox-induced cardiotoxicity are still not fully under
Externí odkaz:
https://doaj.org/article/e54bc7605db149d5b5e6bfe4e4348f1b
Publikováno v:
Diabetes and Vascular Disease Research. 15:263-269
Propose: To investigate the temporal relationship between plasma fibroblast growth factor 21 levels, insulin resistance, metabolic dysfunction and cardiac fibroblast growth factor 21 resistance in long-term high-fat diet–induced obese rats. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d96ddeb5e2ec3ff660f6b166ec607b15
https://doi.org/10.1177/1479164118757152
https://doi.org/10.1177/1479164118757152
Autor:
Anchalee Pongchaidecha, Sakawdaurn Yasom, Keerati Wanchai, Sasiwan Kerdphoo, Nipon Chattipakorn, Wasana Pratchayasakul, Sathima Eaimworawuthikul, Nattayaporn Apaijai, Parameth Thiennimitr, Titikorn Chunchai, Pongpan Tanajak, Anusorn Lungkaphin, Wannipa Tunapong, Siriporn C. Chattipakorn
Publikováno v:
European Journal of Nutrition. 57:2091-2104
In metabolic syndrome, the composition of gut microbiota has been disrupted, and is associated with left ventricular (LV) dysfunction. Several types of prebiotics, probiotics, and synbiotics have been shown to exert cardioprotection by restoring gut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f6ef768544aa0a2d1dfb74e21593a89
https://doi.org/10.1007/s00394-017-1482-3
https://doi.org/10.1007/s00394-017-1482-3
Autor:
Siriporn C. Chattipakorn, Pongpan Tanajak, Linlada Leelarphat, Pattarapong Satjaritanun, Hiranya Pintana, Nipon Chattipakorn, Wasana Pratchayasakul, Titikorn Chunchai, Piangkwan Sa-nguanmoo
Publikováno v:
British Journal of Nutrition. 116:1700-1708
Dipeptidyl peptidase-4 (DDP-4) inhibitors and energy restriction (ER) are widely used to treat insulin resistance and type 2 diabetes mellitus. However, the effects of ER or the combination with vildagliptin on brain insulin sensitivity, brain mitoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16326a65baaec7848c3b05f3d9bb1e42
https://doi.org/10.1017/s0007114516003871
https://doi.org/10.1017/s0007114516003871
Autor:
Chao Jiang, Siriporn C. Chattipakorn, Pongpan Tanajak, Guang Liang, Nipon Chattipakorn, Piangkwan Sa-nguanmoo, Xiaojie Wang, Xiaokun Li
Publikováno v:
Acta Physiologica. 217:287-299
Fibroblast growth factor 21 (FGF21) acts as a metabolic regulator and exerts cardioprotective effects. However, the effects of long term FGF21 administration on the heart under the FGF21 resistant condition in obese-insulin resistant rats have not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46651af03ae57b03ef80ce3ba6ce4d7e
https://doi.org/10.1111/apha.12698
https://doi.org/10.1111/apha.12698
Publikováno v:
Journal of Endocrinology. 227:R13-R30
Fibroblast growth factor 21 (FGF21) is a novel polypeptide ligand that has been shown to be involved in several physiological and pathological processes including regulation of glucose and lipids as well as reduction of arteriosclerotic plaque format
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d80f1c29be5dfc4b75f0304a23b475e0
https://doi.org/10.1530/joe-15-0289
https://doi.org/10.1530/joe-15-0289
Autor:
Savitree Thummasorn, Pongpan Tanajak, Watthana Nuntaphum, Krekwit Shinlapawittayatorn, Nipon Chattipakorn, Juthamas Khamseekaew, Kannaporn Intachai, Wanpitak Pongkan, Suwakon Wongjaikam, Siriporn C. Chattipakorn
Publikováno v:
Basic research in cardiology. 113(4)
Vagus nerve stimulation (VNS) has been shown to exert cardioprotection against myocardial ischemia/reperfusion (I/R) injury. However, whether the cardioprotection of VNS is mainly due to direct activation through its ipsilateral efferent fibers (moto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4db8c101c8b50151a5ab974e96c6c8
https://pubmed.ncbi.nlm.nih.gov/29744667
https://pubmed.ncbi.nlm.nih.gov/29744667
Autor:
Sivaporn Sivasinprasasn, Pongpan Tanajak, Natthaphat Siri-Angkul, Siriporn C. Chattipakorn, Savitree Thummasorn, Piangkwan Sa-nguanmoo, Nipon Chattipakorn
Publikováno v:
The Journal of endocrinology. 236(2)
Sodium-glucose cotransporter 2 inhibitor (SGLT2-i) effects on cardiac ischemia/reperfusion (I/R) injury are unclear. Unlike SGLT2-i, dipeptidyl peptidase 4 inhibitors (DPP4-i) have shown effective cardioprotection in cardiac I/R injury. We aimed to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f094e3b806d5d5fd036a45246fa191f4
https://pubmed.ncbi.nlm.nih.gov/29142025
https://pubmed.ncbi.nlm.nih.gov/29142025
Autor:
Guang Liang, Thidarat Jaiwongkam, Chao Jiang, Xiaokun Li, Piangkwan Sa-nguanmoo, Nipon Chattipakorn, Wasana Pratchayasakul, Xiaojie Wang, Siriporn C. Chattipakorn, Sasiwan Kerdphoo, Pongpan Tanajak
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 97
The beneficial effects of Fibroblast Growth Factor 21 (FGF21) on metabolic function and neuroprotection have been shown in earlier research. We have previously shown that the Dipeptidyl Peptidase 4 inhibitor, vildagliptin, also led to improved insuli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5e95c3ae089b6db14f031cfed692f8
https://pubmed.ncbi.nlm.nih.gov/29793329
https://pubmed.ncbi.nlm.nih.gov/29793329
Autor:
Nipon Chattipakorn, Pongpan Tanajak, Panan Suntornsaratoon, Siriporn C. Chattipakorn, Jarinthorn Teerapornpuntakit, Narattaphol Charoenphandhu, Ratchaneevan Aeimlapa, Piangkwan Sa-nguanmoo
Publikováno v:
Canadian journal of diabetes. 42(5)
Objective Obese insulin resistance and type 2 diabetes mellitus profoundly impair bone mechanical properties and bone quality. However, because several antidiabetes drugs, especially thiazolidinediones, further aggravate bone loss in individuals with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::164de4f6f620b582bf3547fcc22cca1d
https://pubmed.ncbi.nlm.nih.gov/29606326
https://pubmed.ncbi.nlm.nih.gov/29606326